Gregory Chow
Vermögen: 95 634 $ am 31.08.2026
Vermögen: 95 634 $ am 31.08.2026
Gregory K.
Chow is Chief Financial & Accounting Officer at Sutro Biopharma, Inc. since 2025.
Formerly, Mr. Chow was Chief Financial & Business Officer at NodThera Ltd. from 2024 to 2025, Chief Financial Officer at Aptose Biosciences, Inc. from 2013 to 2021, Managing Director & Director-Private Placements at Wedbush Securities, Inc. from 2012 to 2013, Director-Private Placements at RBC Capital Markets, Inc. from 2006 to 2011, Chief Financial Officer at Freenome Holdings, Inc., Chief Financial Officer at Frontier Medicines Corp., and Senior Auditor at BDO USA PC from 1995 to 1998.
Education includes an undergraduate degree from the University of California, Santa Barbara in 1994 and an MBA from The Wharton School of the University of Pennsylvania in 2005.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.06.2026 | 4’725 ( 0.03% ) | 95 634 $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Finanzdirektor/CFO | 02.06.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Finanzdirektor/CFO | 01.03.2025 |
| APTOSE BIOSCIENCES INC. | Finanzdirektor/CFO | 26.03.2021 |
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Vorstandsvorsitzender | 01.01.2013 |
RBC Capital Markets, Inc.
RBC Capital Markets, Inc. Investment ManagersFinance Provides investment advice | Corporate Officer/Principal | 01.01.2011 |
BDO USA PC
BDO USA PC Miscellaneous Commercial ServicesCommercial Services Provides assurance, tax and financial advisory services | Comptroller/Controller/Auditor | 01.08.1998 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Aptose Biosciences, Inc.
Aptose Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, research and develops anticancer therapies with high safety profiles | Health Technology |
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Finance |
Sutro Biopharma, Inc.
Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
BDO USA PC
BDO USA PC Miscellaneous Commercial ServicesCommercial Services Provides assurance, tax and financial advisory services | Commercial Services |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RBC Capital Markets, Inc.
RBC Capital Markets, Inc. Investment ManagersFinance Provides investment advice | Finance |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Freenome Holdings, Inc.
Freenome Holdings, Inc. Medical SpecialtiesHealth Technology Operates as an early cancer detection company that develops blood-based screening tests | Health Technology |
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Health Technology |
Frontier Medicines Corp.
Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutics for oncology & immunology | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen